MIRRO 
2 
Research Interests: 
Mixed lineage leukemia 
Therapeutic trials in myeloid leukemia 
Autologous marrow transplantation 
Societies : 
Alpha Omega Alpha 
American Society of Clinical Oncology 
American Society of Hematology 
American Association for the Advancement of Science 
Society for Pediatric Research 
International Society of Hematology 
Grant Support: 
NCI POl CA 20180 - Cell kinetics section of the Leukemia Program Project Grant; 
9/1/77-4/30/84; -04 $60,419; -05 $94,101; -06 $99,747; 30Z effort, 29X salary. 
Sharon Murphy, M.D. , Principal Investigator; Joseph V. Simone, M.D., Program 
Director 
Burroughs Wellcome; In vitro Wellferon studies; 2/1/83 - 1/30/85; $36,000, Joseph 
Mirro, Jr. M.D. , Principal Investigator 
American Cancer Society; Clinical Oncology Career Development Award; 7/1/85 - 
6/30/88; -01 $25,000; -02 $30,000; -03 $30,000, Joseph Mirro, Jr. M.D. , Principal 
Investigator 
American Cancer Society; Immunoglobulin gene rearrangement/expression in leu- 
kemia; 1/1/86 to 12/30/87; $200,000. Geoffrey Kitchingman, Ph.D. , Principal 
Investigator, Joseph Mirro, Jr., M.D. , Co- investigator . 
NCI POl CA 20180 - Treatment of acute nonlymphocytic leukemia; 9/1/87-8/30/90; - 
10 $152,765; -11 $137,596; -12 $145,853: 40Z effort, 20Z salary. Joseph Mirro, 
Jr., M.D. , Principal Investigator, A. Thomas Look, M.D., Program Director. 
NCI 5-ROl CA 43237-02; 2/1/89 - 1/30/90; lOZ effort. R. Goorha, Ph.D., Principal 
Investigator, Joseph Mirro Jr., M.D. , Co- Investigator . 
Pending Grant Support 
NCI POl CA 20180 - Treatment of acute nonlymphocytic leukemia; Joseph Mirro, Jr. , 
M.D., Principal Investigator, Project 2. 
NCI POl CA 20180 - The biology of acute nonlymphocytic leukemia; James N. Ihle , 
Ph.D., Principal Investigator, Joseph Mirro, Jr., M.D., Co-Principal 
Investigator, Project 5. 
Recombinant DNA Research, Volume 14 
[551] 
